The substantially higher levels of FcRn in HCC1419 cells compared with the other breast and prostate cancer cell lines analyzed (Figure 1) provided us with a tool to investigate the effect of reduced FcRn expression on tumor cell line behavior. This evidence concerns the gene FCGRT and prostate carcinoma.